Skip to main content
. 2019 Sep 27;20(19):4811. doi: 10.3390/ijms20194811
BCLC Barcelona Cancer Liver Clinic
BID bis in die
ECOG Eastern Cooperative Oncology Group
HCC hepatocellular carcinoma
IM intramuscularly
LAR long-acting release
PO per oral
RCT randomized clinical trial
RFA Radio frequency ablation
SC subcutaneously
SST somatostatin
SSTR somatostatin receptor
TACE transarterial chemoembolization
TID ter in die